Table 1.

Clinical-pathologic characteristics of the 12 breast cancer samples in this study

Patient	Age	Grade	Stage	ER status	PR status	HER2 status
16H	[50–60)	3	III	P	P	N
16 J	[40–50)	1	II	P	P	N
16 K	[40–50)	2	II	P	P	N
16 W	[70–80)	2	I	P	N	N
17E	[60–70)	2	I	P	P	N
18Y	[40–50)	2	I	P	P	P
19A	[50–60)	2	II	P	P	N
19D	[80–90)	3	III	P	P	N
19G	[50–60)	2	II	P	N	N
19 K	[50–60)	2	II	P	P	N
19 M	[40–50)	3	I	P	P	N
19O	[50–60)	2	II	P	P	N